Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Critchley

Showing results (81-90 of 91) with videos related to

Pageof 10
Sort By:
International Journal of Cardiology|April 28, 2016
Erratum to "Exploring potential mortality reductions in 9 European countries by improving diet and lifestyle: A modelling approach" [Int. J. Cardiol. 207 (2016) 286-291]M O'Flaherty, P Bandosz, J Critchley, et al.
International Journal of Cardiology|January 27, 2016
Exploring potential mortality reductions in 9 European countries by improving diet and lifestyle: A modelling approachM O'Flaherty, P Bandosz, J Critchley, et al.
The American Journal of Gastroenterology|February 22, 2020
Independent Blinded Validation of a Tissue Systems Pathology Test to Predict Progression in Patients With Barrett's EsophagusJon M Davison, John Goldblum, Udhayvir Singh Grewal, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 20, 2009
Impaired interferon signaling is a common immune defect in human cancerRebecca J Critchley-Thorne, Diana L Simons, Ning Yan, et al.
Glycobiology|May 30, 2003
Detailed glycan analysis of serum glycoproteins of patients with congenital disorders of glycosylation indicates the specific defective glycan processing step and provides an insight into pathogenesisMichael Butler, D Quelhas, Alison J Critchley, et al.
Clinical and Translational Gastroenterology|August 25, 2023
A Tissue Systems Pathology Test Outperforms the Standard-of-Care Variables in Predicting Progression in Patients With Barrett's EsophagusJon M Davison, John R Goldblum, Lucas C Duits, et al.
The American Journal of Gastroenterology|May 13, 2021
Tissue Systems Pathology Test Objectively Risk Stratifies Barrett's Esophagus Patients With Low-Grade DysplasiaNicola F Frei, Amir M Khoshiwal, Kadere Konte, et al.
Cell Reports. Medicine|May 14, 2026
Therapeutic activity of a hematopoietic stem cell-delivered cell-penetrating frataxin in Friedreich's ataxia modelsJeffrey Pido-Lopez, Shefta E Moula, Enas Shaban, et al.
Behavioural Brain Research|January 1, 1996
Electrophysiological, biochemical, neurohormonal and behavioural studies with WAY-100635, a potent, selective and silent 5-HT1A receptor antagonistA Fletcher, E A Forster, D J Bill, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 13, 2016
A Tissue Systems Pathology Test Detects Abnormalities Associated with Prevalent High-Grade Dysplasia and Esophageal Cancer in Barrett's EsophagusRebecca J Critchley-Thorne, Jon M Davison, Jeffrey W Prichard, et al.
Pageof 10

Showing results (81-90 of 91) with videos related to

Sort By:
Pageof 10
International Journal of Cardiology|April 28, 2016
Erratum to "Exploring potential mortality reductions in 9 European countries by improving diet and lifestyle: A modelling approach" [Int. J. Cardiol. 207 (2016) 286-291]M O'Flaherty, P Bandosz, J Critchley, et al.
International Journal of Cardiology|January 27, 2016
Exploring potential mortality reductions in 9 European countries by improving diet and lifestyle: A modelling approachM O'Flaherty, P Bandosz, J Critchley, et al.
The American Journal of Gastroenterology|February 22, 2020
Independent Blinded Validation of a Tissue Systems Pathology Test to Predict Progression in Patients With Barrett's EsophagusJon M Davison, John Goldblum, Udhayvir Singh Grewal, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 20, 2009
Impaired interferon signaling is a common immune defect in human cancerRebecca J Critchley-Thorne, Diana L Simons, Ning Yan, et al.
Glycobiology|May 30, 2003
Detailed glycan analysis of serum glycoproteins of patients with congenital disorders of glycosylation indicates the specific defective glycan processing step and provides an insight into pathogenesisMichael Butler, D Quelhas, Alison J Critchley, et al.
Clinical and Translational Gastroenterology|August 25, 2023
A Tissue Systems Pathology Test Outperforms the Standard-of-Care Variables in Predicting Progression in Patients With Barrett's EsophagusJon M Davison, John R Goldblum, Lucas C Duits, et al.
The American Journal of Gastroenterology|May 13, 2021
Tissue Systems Pathology Test Objectively Risk Stratifies Barrett's Esophagus Patients With Low-Grade DysplasiaNicola F Frei, Amir M Khoshiwal, Kadere Konte, et al.
Cell Reports. Medicine|May 14, 2026
Therapeutic activity of a hematopoietic stem cell-delivered cell-penetrating frataxin in Friedreich's ataxia modelsJeffrey Pido-Lopez, Shefta E Moula, Enas Shaban, et al.
Behavioural Brain Research|January 1, 1996
Electrophysiological, biochemical, neurohormonal and behavioural studies with WAY-100635, a potent, selective and silent 5-HT1A receptor antagonistA Fletcher, E A Forster, D J Bill, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 13, 2016
A Tissue Systems Pathology Test Detects Abnormalities Associated with Prevalent High-Grade Dysplasia and Esophageal Cancer in Barrett's EsophagusRebecca J Critchley-Thorne, Jon M Davison, Jeffrey W Prichard, et al.
Pageof 10